Login
$HNGE
$121.75 +$0.46 (0.38%) After hours

$HNGE SEC Filings

Filed On Filing
13 Nov 2026 Form 4: Robinson Elliott, Director

Sold 0 shares · Sold 0 shares · Sold 0 shares

12 Nov 2026 Form 4: Mecklenburg Gabriel M.i., Director

Received 200,000 shares by conversion · Sold 200,000 shares ($24.5M)

12 Nov 2026 Form 4: Budge James, Chief Financial Officer

Sold 35,907 shares ($4.37M)

12 Nov 2026 144
10 Nov 2026 144
09 Nov 2026 10-Q
06 Nov 2026 Form 4: Robinson Elliott, Director

Sold 0 shares · Sold 0 shares

02 Nov 2026 Form 4: Budge James, Chief Financial Officer

Gave up 4,614 shares to cover exercise price or tax ($527K)

02 Nov 2026 Form 4: Pursley James, President

Gave up 831 shares to cover exercise price or tax ($95K)

02 Nov 2026 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more

San Francisco, California – November 2, 2026 – Hinge Health, Inc. (NYSE: HNGE) today announced financial results for the third quarter ended September 30, 2026 and provided a business update.

14 Oct 2026 144
14 Oct 2026 144
14 Oct 2026 144
14 Oct 2026 144
13 Oct 2026 Form 4: Budge James, Chief Financial Officer

Sold 47,720 shares ($4.92M)

13 Oct 2026 Form 4: Mecklenburg Gabriel M.i., Director

Received 200,000 shares by conversion · Sold 200,000 shares ($20.6M)

13 Oct 2026 144
13 Oct 2026 144
07 Oct 2026 Form 4: Perez Daniel Antonio, Director

Received 4,100 shares by conversion · Sold 4,100 shares ($411K)

06 Oct 2026 144

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support